SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

NGL Fine-Chem - Quaterly Results

04 Aug 2023 Evaluate
The June 2023 quarter revenue stood at Rs. 691.13 millions, up 8.71% as compared to Rs. 635.77 millions during the corresponding quarter last year.The Net Profit of the company vaulted to 1424.61% to Rs. 78.06  millions from Rs. 5.12 millions in the previous quarter.Operating profit surged to 114.03 millions from the corresponding previous quarter of 31.23 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 691.13 635.77 8.71 691.13 635.77 8.71 2750.52 3186.67 -13.69
Other Income 38.02 30.07 26.44 38.02 30.07 26.44 76.12 126.40 -39.78
PBIDT 114.03 31.23 265.13 114.03 31.23 265.13 356.96 782.09 -54.36
Interest 2.43 4.98 -51.20 2.43 4.98 -51.20 11.97 15.62 -23.37
PBDT 111.60 26.25 325.14 111.60 26.25 325.14 344.99 766.47 -54.99
Depreciation 19.99 19.58 2.09 19.99 19.58 2.09 78.99 76.73 2.95
PBT 91.61 6.67 1273.46 91.61 6.67 1273.46 266.00 689.74 -61.43
TAX 13.55 1.55 774.19 13.55 1.55 774.19 64.81 167.28 -61.26
Deferred Tax 1.72 -7.20 -123.89 1.72 -7.20 -123.89 -7.29 -4.22 72.75
PAT 78.06 5.12 1424.61 78.06 5.12 1424.61 201.19 522.46 -61.49
Equity 30.89 30.89 0.00 30.89 30.89 0.00 30.89 30.89 0.00
PBIDTM(%) 16.50 4.91 235.88 16.50 4.91 235.88 12.98 24.54 -47.12

NGL Fine-Chem Share Price

2229.75 -25.30 (-1.12%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×